Research Article| Volume 25, ISSUE 3, P695-701, March 2016

Download started.


Hyperdense Artery Sign, Clot Characteristics, and Response to Intravenous Thrombolysis in Han Chinese People with Acute Large Arterial Infarction


      Whether the presence of hyperdense artery sign (HAS) correlates with clot characteristics and response to intravenous thrombotic therapy (IVT) remains to be determined. Given that the existent literature was mainly from the Western nations, the current study aimed to examine the relationships among HAS, clot characteristics, and outcome of IVT in a Han Chinese sample in Taiwan. The specific objectives are (1) to correlate HAS with clot characteristics and (2) to explore relationships between HAS and effectiveness/complication of IVT.


      We enrolled 75 patients treated with IVT following acute large arterial infarctions. All patients had a baseline brain computed tomography and a follow-up image at 24 hours after thrombolysis. Correlations were explored between HAS and clot characteristics. Multivariable logistic regressions were employed to examine the relationships between HAS and response to IVT at 24 hours, including early improvement and all forms of intracerebral hemorrhage (ICH).


      In this Han Chinese sample in Taiwan, 50.7% of the patients had HAS and 64% had early improvements following IVT. Those with HAS tended to have clots lodging at main trunks of cerebral arteries but no significant associations were found between HAS and stroke etiology. In multivariable logistic regressions, HAS predicted neither early improvement nor ICH complication.


      Instead of clot etiology, we found that it might be clot location that correlated with HAS. HAS was not associated with early improvement or ICH complication after IVT in this Han Chinese sample. We also showed that some other patient characteristics were likely to influence outcomes of IVT, which warrant clinical attention.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Aries M.J.
        • Uyttenboogaart M.
        • Koopman K.
        • et al.
        Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke.
        J Neurol Sci. 2009; 285: 114-117
        • Kharitonova T.
        • Ahmed N.
        • Thoren M.
        • et al.
        Hyperdense middle cerebral artery sign on admission CT scan—prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register.
        Cerebrovasc Dis. 2009; 27: 51-59
        • Abul-Kasim K.
        • Brizzi M.
        • Petersson J.
        Hyperdense middle cerebral artery sign is an ominous prognostic marker despite optimal workflow.
        Acta Neurol Scand. 2010; 122: 132-139
        • Qureshi A.I.
        • Ezzeddine M.A.
        • Nasar A.
        • et al.
        Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?.
        Neurology. 2006; 66: 1171-1174
        • Tartaglia M.C.
        • Di Legge S.
        • Saposnik G.
        • et al.
        Acute stroke with hyperdense middle cerebral artery sign benefits from IV rtPA.
        Can J Neurol Sci. 2008; 35: 583-587
        • Gacs G.
        • Fox A.J.
        • Barnett H.J.
        • et al.
        CT visualization of intracranial arterial thromboembolism.
        Stroke. 1983; 14: 756-762
        • Jensen-Kondering U.
        • Riedel C.
        • Jansen O.
        Hyperdense artery sign on computed tomography in acute ischemic stroke.
        World J Radiol. 2010; 2: 354-357
        • Liebeskind D.S.
        • Sanossian N.
        • Yong W.H.
        • et al.
        CT and MRI early vessel signs reflect clot composition in acute stroke.
        Stroke. 2011; 42: 1237-1243
        • Gersh K.C.
        • Nagaswami C.
        • Weisel J.W.
        Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes.
        Thromb Haemost. 2009; 102: 1169-1175
        • Jang I.K.
        • Gold H.K.
        • Ziskind A.A.
        • et al.
        Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.
        Circulation. 1989; 79: 920-928
        • Kirchhof K.
        • Sikinger M.
        • Welzel T.
        • et al.
        [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
        Rofo. 2004; 176: 98-105
        • Puig J.
        • Pedraza S.
        • Demchuk A.
        • et al.
        Quantification of thrombus Hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator.
        AJNR Am J Neuroradiol. 2012; 33: 90-96
        • Kimura K.
        • Iguchi Y.
        • Shibazaki K.
        • et al.
        The presence of a right-to-left shunt is associated with dramatic improvement after thrombolytic therapy in patients with acute ischemic stroke.
        Stroke. 2009; 40: 303-305
        • Kim E.Y.
        • Heo J.H.
        • Lee S.K.
        • et al.
        Prediction of thrombolytic efficacy in acute ischemic stroke using thin-section noncontrast CT.
        Neurology. 2006; 67: 1846-1848
        • Niesten J.M.
        • van der Schaaf I.C.
        • van der Graaf Y.
        • et al.
        Predictive value of thrombus attenuation on thin-slice non-contrast CT for persistent occlusion after intravenous thrombolysis.
        Cerebrovasc Dis. 2014; 37: 116-122
        • Li Q.
        • Davis S.
        • Mitchell P.
        • et al.
        Proximal hyperdense middle cerebral artery sign predicts poor response to thrombolysis.
        PLoS ONE. 2014; 9: e96123
        • Kimura K.
        • Iguchi Y.
        • Shibazaki K.
        • et al.
        M1 susceptibility vessel sign on T2* as a strong predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
        Stroke. 2009; 40: 3130-3132
        • Kimura K.
        • Sakamoto Y.
        • Aoki J.
        • et al.
        Clinical and MRI predictors of no early recanalization within 1 hour after tissue-type plasminogen activator administration.
        Stroke. 2011; 42: 3150-3155
        • Wohner N.
        • Sótonyi P.
        • Machovich R.
        • et al.
        Lytic resistance of fibrin containing red blood cells.
        Arterioscler Thromb Vasc Biol. 2011; 31: 2306-2313
        • Derex L.
        • Hermier M.
        • Adeleine P.
        • et al.
        Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator.
        J Neurol Neurosurg Psychiatry. 2005; 76: 70-75
        • Zou M.
        • Churilov L.
        • He A.
        • et al.
        Hyperdense middle cerebral artery sign is associated with increased risk of hemorrhagic transformation after intravenous thrombolysis for patients with acute ischaemic stroke.
        J Clin Neurosci. 2013; 20: 984-987
        • Tomsick T.
        • Brott T.
        • Barsan W.
        • et al.
        Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy.
        AJNR Am J Neuroradiol. 1996; 17: 79-85
        • Kim B.J.
        • Kim J.S.
        Ischemic stroke subtype classification: an Asian viewpoint.
        J Stroke. 2014; : 1-10
        • Ramaiah S.S.
        • Yan B.
        Low-dose tissue plasminogen activator and standard-dose tissue plasminogen activator in acute ischemic stroke in Asian populations: a review.
        Cerebrovasc Dis. 2013; 36: 161-166
        • Sharma V.K.
        • Ng K.W.
        • Venketasubramanian N.
        • et al.
        Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
        Int J Stroke. 2011; 6: 523-530
        • Hsieh F.I.
        • Lien L.M.
        • Chen S.T.
        • et al.
        Get with the guidelines-stroke performance indicators: surveillance of stroke care in the Taiwan stroke registry: get with the guidelines-stroke in Taiwan.
        Circulation. 2010; 122: 1116-1123
        • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
        Tissue plasminogen activator for acute ischemic stroke.
        N Engl J Med. 1995; 333: 1581-1587
        • Koo C.K.
        • Teasdale E.
        • Muir K.W.
        What constitutes a true hyperdense middle cerebral artery sign?.
        Cerebrovasc Dis. 2000; 10: 419-423
        • Jha B.
        • Kothari M.
        Pearls & oy-sters: hyperdense or pseudohyperdense MCA sign: a Damocles sword?.
        Neurology. 2009; 72: e116-e117
        • Kenmuir C.
        • Totoraitis R.V.
        • Jovin T.
        • et al.
        Hyperdense middle cerebral artery sign.
        Practical neurology. 2014; 14: 264-265
        • Adams Jr, H.P.
        • Bendixen B.H.
        • Kappelle L.J.
        • et al.
        Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
        Stroke. 1993; 24: 35-41
        • Riedel C.H.
        • Jensen U.
        • Rohr A.
        • et al.
        Assessment of thrombus in acute middle cerebral artery occlusion using thin-slice nonenhanced computed tomography reconstructions.
        Stroke. 2010; 41: 1659-1664
        • Novotna J.
        • Kadlecova P.
        • Czlonkowska A.
        • et al.
        Hyperdense cerebral artery computed tomography sign is associated with stroke severity rather than stroke subtype.
        J. Stroke Cerebrovasc. Dis. 2014; 23: 2533-2539
        • Agarwal P.
        • Kumar S.
        • Hariharan S.
        • et al.
        Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?.
        Cerebrovasc. Dis. 2004; 17: 182-190
        • Paliwal P.R.
        • Ahmad A.
        • Shen L.
        • et al.
        Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
        Cerebrovasc. Dis. 2012; 33: 446-452
        • Topcuoglu M.A.
        • Arsava E.M.
        • Kursun O.
        • et al.
        The utility of middle cerebral artery clot density and burden assessment by noncontrast computed tomography in acute ischemic stroke patients treated with thrombolysis.
        J. Stroke Cerebrovasc. Dis. 2014; 23: e85-e91
        • Marder V.J.
        • Chute D.J.
        • Starkman S.
        • et al.
        Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke.
        Stroke. 2006; 37: 2086-2093
        • Niesten J.M.
        • van der Schaaf I.C.
        • Biessels G.J.
        • et al.
        Relationship between thrombus attenuation and different stroke subtypes.
        Neuroradiology. 2013; 55: 1071-1079
        • Topcuoglu M.A.
        • Arsava E.M.
        • Akpinar E.
        Clot characteristics on computed tomography and response to thrombolysis in acute middle cerebral artery stroke.
        J. Stroke Cerebrovasc. Dis. 2015; 24: 1363-1372
        • Tan I.Y.
        • Demchuk A.M.
        • Hopyan J.
        • et al.
        CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct.
        AJNR Am J Neuroradiol. 2009; 30: 525-531
        • Riedel C.H.
        • Zimmermann P.
        • Jensen-Kondering U.
        • et al.
        The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length.
        Stroke. 2011; 42: 1775-1777
        • Bhatia R.
        • Hill M.D.
        • Shobha N.
        • et al.
        Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.
        Stroke. 2010; 41: 2254-2258
        • Padjen V.
        • Bodenant M.
        • Jovanovic D.R.
        • et al.
        Outcome of patients with atrial fibrillation after intravenous thrombolysis for cerebral ischaemia.
        J Neurol. 2013; 260: 3049-3054